State Street
OMIC

State Street’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

State Street’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,754
Closed -$57.9K – 4417
2024
Q1 		$57.9K Hold
3,754
– – ﹤0.01% 4132
2023
Q4 		$51.8K Hold
3,754
– – ﹤0.01% 4190
2023
Q3 		$42.9K Sell
3,754
-900
-19% -$16.7K ﹤0.01% 4321
2023
Q2 		$116K Sell
4,654
-24,976
-84% -$732K ﹤0.01% 4195
2023
Q1 		$1.08M Buy
29,630
+24
+0.1% +$1.47K ﹤0.01% 3517
2022
Q4 		$1.79M Buy
29,606
+2,572
+10% +$172K ﹤0.01% 3408
2022
Q3 		$2.03M Buy
27,034
+2,249
+9% +$235K ﹤0.01% 3410
2022
Q2 		$2.84M Buy
24,785
+7,617
+44% +$893K ﹤0.01% 3362
2022
Q1 		$3.25M Buy
17,168
+10,658
+164% +$2.47M ﹤0.01% 3378
2021
Q4 		$2.26M Buy
6,510
+2,662
+69% +$1.03M ﹤0.01% 3599
2021
Q3 		$1.29M Buy
+3,848
New +$1.97M ﹤0.01% 3731

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

State Street's OMIC Position: Q2 2024 in Review

State Street sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2024, closing a stake of 3,754 shares — an estimated $57.9K sold.

State Street first reported a position in OMIC in Q3 2021 and held it in 11 quarters. The position peaked at $3.25M in Q1 2022. 24 funds tracked by Wall St. Rank hold OMIC as of Q2 2024.

  • State Street reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • State Street sold 3,754 Singular Genomics Systems, Inc. Common Stock shares in Q2 2024, an estimated $57.9K.
  • State Street first reported a position in Singular Genomics Systems, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
  • State Street's Singular Genomics Systems, Inc. Common Stock position peaked at $3.25M in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2024.

Based on State Street's 13F filing for Q2 2024, filed 14 Aug 2024.